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OBJECTIVE—To evaluate whether fasting plasma glucose (FPG) within a normoglycemic
range is associated with cardiometabolic risk factors (CMRF) among children and adolescents
in an outpatient setting.
RESEARCHDESIGNANDMETHODS—Subjects(780;age6–16years)withFPG,100
mg/dL were divided into tertiles of FPG.
RESULTS—BMI, waist circumference, homeostasis model assessment-insulin resistance, sys-
tolic blood pressure, and white blood cell (WBC) count (P , 0.0001) increased across tertiles of
FPG. Subjects with high-normal FPG (89–99 mg/dL) showed a higher risk of insulin resistance,
hypertension, and highWBC count comparedwithsubjectswithlow-normalFPG, independent
of BMI z score.
CONCLUSIONS—In outpatient children and adolescents, higher FPG within the normal
range is associated with several CMRF, independent of obesity. Thus the simple measurement of
FPG may help identify subjects who warrant some monitoring in relation to cardiovascular risk.
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T
he prevalence of prediabetes, de-
ﬁned as impaired fasting glucose
(IFG) and/or impaired glucose tol-
erance (IGT), is increasing in the pedi-
atric population (1). Similar to adults,
prediabetes in children is associated
with both an elevated risk of developing
type2diabetesandaworsenedcardiovas-
cular risk proﬁle compared with normo-
glycemic subjects (2,3). Recent studies
have shown that in obese children some
impairmentofglucosehomeostasismight
already be present at fasting glucose con-
centrations below the threshold for IFG
(4–6). However, the question whether
fasting plasma glucose (FPG) in the nor-
mal range is associated with some cardio-
metabolic risk factors (CMRF) is little
explored. Therefore, we assessed whether
FPG clustered with CMRF in an outpa-
tient setting of normoglycemic Caucasian
children and adolescents. In addition we
evaluated whether subjects with high-
normal FPG showed a worse cardiometa-
bolic risk proﬁle.
RESEARCH DESIGN AND
METHODS—Our population consisted
of 780 Southern European Caucasian
children and adolescents (age 6–16 years)
consecutively observed in the Outpatient
Unit of Pozzuoli Hospital in the period
2004–2009. One hundred ninety-eight
(25%) were normal weight, 174 (22%)
were overweight, and 408 (52%) were
obese. All subjects had been referred to
our unit by their general practitioners be-
cause of allergy problems, overweight, or
obesity. None were under pharmacologi-
cal treatment. Subjects with IFG; diabe-
tes; and gastrointestinal, cardiac, renal,
urinary, and infectious diseases were ex-
cluded. Anthropometric measurements
and blood pressure (BP) were obtained
with standard methods as elsewhere de-
scribed (7). Biochemical and hematologi-
cal variables were centrally analyzed
according to standard procedures. Insulin
sensitivity was evaluated by the homeo-
stasis model assessment-insulin resis-
tance (HOMA-IR). Overweight and
obesity were deﬁned using Italian growth
charts, according to individual BMI
$85th and $95th percentile for age and
sex, respectively (8). Hypertension was
deﬁned by BP $95th percentile for age,
sex, and height as elsewhere reported (9).
IR was deﬁned by 95th percentile of
HOMA-IR values obtained in healthy
nonobese Italian children categorized ac-
cording to Tanner stage (10). High white
blood cell (WBC) count was deﬁned by
av a l u e$9.0 (10
3/L) corresponding to
the 80th percentile of our population.
The local ethics committee approved the
study, and informed consent was ob-
tained from all children’s parents. Data
were analyzed by ANOVA, x
2,a n dm u l -
tiple logistic regression analysis using
SPSS for Windows, version 13.0 (SPSS,
Chicago, IL).
RESULTS—Table 1 shows the features
of subjects according to tertiles of FPG:
low-normal (#82 mg/dL), mid-normal
(83–88 mg/dL), and high-normal (89–
99 mg/dL). Age and Tanner stage were
similar among the three categories of
FPG.Thepercentageofmalesexandobe-
sity increased across categories of FPG
(P , 0.001).From thelowest to the high-
est tertile of FPG, we observed a signiﬁ-
cantincreaseinBMI,waistcircumference,
HOMA-IR, systolic BP, and WBC count
(P,0.0001).Nodifferencewasobserved
for HbA1c and lipid proﬁle. At multiple
logistic regression analysis (controlled
for age, sex, Tanner stage, allergy, and
BMI z score), subjects with high-normal
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pertension, and high WBC count com-
p a r e dw i t hs u b j e c t sw i t hl o w - n o r m a l
FPG(Table1).Thegroupwithmid-normal
FPG,ascomparedwiththelow-normalFPG,
showed an increased risk of IR and hyper-
tension,butnotofhighWBCcount.These
resultsdidnotchangewhenthecategoryof
overweight/obesity was included into the
model instead of BMI z score.
CONCLUSIONS—Thisstudydemon-
strates that in an outpatient setting of
normoglycemic Caucasian children and
adolescents, FPG is associated with sev-
eral CMRF, independent of obesity. In
adults, a high but normal FPG is a risk
factor for development of type 2 diabetes
(11) and cardiovascular disease (12). Pre-
vious studies exploring the clinical signif-
icance of high-normal FPG in children
have been performed in obese subjects
(4–6). In a sample of 323 obese children,
Grandone et al. (5) showed that high-
normal FPG (87–99 mg/dL) is associated
with a sevenfold higher risk of present-
ing IGT and IR. More recently, O’Malley
et al. (6) reported a reduction in both
insulin sensitivity and b-cell function at
increasing FPG in normoglycemic multi-
ethnic obese youth, thus demonstrating
that some deterioration of glucose ho-
meostasis is already present at apparently
normal FPG. Our study extends this ob-
servation by demonstrating that FPG is
associated with a cluster of CMRF and
demonstrates that this relation is inde-
pendent of BMI. Actually, subjects with
FPG between 89 and 99 mg/dL not only
present IR but also show a 60% increased
risk of hypertension and a 30% increased
risk of high WBC count than those with
FPG #82 mg/dL.
A positive association between FPG
andBPhas been previouslydemonstrated
in children with IFG (2). Our study pro-
vides the novel evidence that this relation
is also present at FPG within the normal
range. Thus the ﬁnding of a high-normal
FPG in a clinical setting could contribute
to an early detection of elevated BP levels,
a condition frequently underestimated in
childhood (13).
An increased WBC count has been
recently reported in children and adoles-
cents with the metabolic syndrome (14).
Weshowthatthistraitisdetectablealsoin
children with high-normal FPG, indicating
that systemic inﬂammation may appear
early in life and be related to subclinical ab-
normalities of glucose metabolism.
Inconclusion,inanoutpatientsetting
of Caucasian children and adolescents,
FPGwithinthenormalrangeisassociated
with several CMRF, independent of obe-
sity. Subjects with high-normal FPG show
a worse cardiometabolic proﬁle than those
with low-normal FPG. Although our ob-
servations need to be conﬁrmed in the
general pediatric population, the simple
measurement of FPG may help in identify-
ing children who warrant some monitor-
ing. Longitudinal studies will conﬁrm
whether high-normal FPG in childhood
could be considered a marker ofcardiovas-
cularriskandapredictorofhardoutcomes
in adulthood.
Acknowledgments—Nopotentialconﬂictsof
interest relevant to this article were reported.
P.D.B. had the original idea and wrote the
manuscript. E.S., C.F., and F.S. collected clin-
ical data. M.R.I. performed biochemical assays.
B.C. reviewed and edited the manuscript.
References
1. Li C, Ford ES, Zhao G, Mokdad AH.
Prevalence of pre-diabetes and its associ-
ation with clustering of cardiometabolic
risk factors and hyperinsulinemia among
U.S. adolescents: National Health and
Nutrition Examination Survey 2005-2006.
Diabetes Care 2009;32:342–347
2. Williams DE, Cadwell BL, Cheng YJ, et al.
Prevalenceofimpairedfastingglucoseand
its relationship with cardiovascular dis-
ease risk factors in US adolescents, 1999-
2000. Pediatrics 2005;116:1122–1126
3. Nguyen QM, Srinivasan SR, Xu JH, Chen
W, Kieltyka L, Berenson GS. Utility of
childhood glucose homeostasis variables
in predicting adult diabetes and related
cardiometabolic risk factors: the Bogalusa
Heart Study. Diabetes Care 2010;33:670–
675
4. Maffeis C, Pinelli L, Brambilla P, et al.
Fasting plasma glucose (FPG) and the risk
of impaired glucose tolerance in obese
children and adolescents. Obesity (Silver
Spring) 2010;18:1437–1442
5. GrandoneA,AmatoA,LuongoC,SantoroN,
Perrone L, del Giudice EM. High-normal
fasting glucose levels are associated with
increased prevalence of impaired glucose
tolerance in obese children. J Endocrinol
Invest 2008;31:1098–1102
6. O’Malley G, Santoro N, Northrup V, et al.
High normal fasting glucose level in obese
youth: a marker for insulin resistance and
beta cell dysregulation. Diabetologia 2010;
53:1199–1209
Table 1—Anthropometric, clinical, and biochemical variables among categories of FPG
and risk of CMRF in children and adolescents
Categories of FPG
Normal
P Low Mid High
n 274 275 231
Age (years) 10 6 31 0 6 31 0 6 3 0.101
Boys (%) 110 (40) 143 (52) 129 (56) 0.001
Prepubertal stage (%) 135 (49) 145 (53) 112 (49) 0.586
Normal weight (%) 92 (33) 61 (22) 45 (20) 0.0001
Overweight (%) 62 (23) 59 (21) 53 (23) 0.554
Obesity (%) 120 (44) 155 (56) 133 (58) 0.001
BMI (kg/m
2)2 4 6 62 5 6 62 6 6 6 0.0001
BMI z score 20.22 6 1.0 0.02 6 0.96 0.19 6 1.02 0.0001
Waist circumference (cm) 77 6 17 82 6 16 85 6 17 0.0001
HOMA-IR 1.9 6 1.4 2.7 6 2.1 3.4 6 2.5 0.0001
HbA1c (%) 5.4 6 0.3 5.4 6 0.3 5.3 6 0.3 0.118
Cholesterol (mg/dL) 162 6 33 163 6 30 161 6 32 0.792
HDL cholesterol (mg/dL) 52 6 11 53 6 11 52 6 12 0.264
Triglycerides (mg/dL) 84 6 40 87 6 44 84 6 36 0.902
BP (mmHg)
Systolic 103 6 11 107 6 12 110 6 13 0.0001
Diastolic 60 6 96 0 6 10 61 6 9 0.542
WBC (10
3/L) 7.1 6 2.4 7.4 6 2.0 7.9 6 2.3 0.0001
Odds ratio (95% CI)^
Insulin resistance 1.00 2.35 (1.43–3.87)* 1.95 (1.52–2.51)†
Hypertension 1.00 2.23 (1.06–3.08)‡ 1.57 (1.07–2.29)§
High WBC count 1.00 1.00 (0.63–1.58) 1.31 (1.05–1.65)§
Data are mean 6 SD or n (%) unless otherwise indicated. ^Adjusted for age, sex, pubertal stage, allergy, and
BMI z score; *P , 0.001; †P , 0.0001; ‡P , 0.05; §P , 0.025.
care.diabetesjournals.org DIABETES CARE, VOLUME 34, JUNE 2011 1413
Di Bonito and Associates7. Di Bonito P, Forziato C, Sanguigno E,
et al. Prehypertension in outpatient obese
children. Am J Hypertens 2009;22:1309–
1313
8. Cacciari E, Milani S, Balsamo A, et al.
Italian cross-sectional growth charts for
height, weight and BMI (2 to 20 yr). J
Endocrinol Invest 2006;29:581–593
9. National High Blood Pressure Education
Program Working Group on High Blood
Pressure in Children and Adolescents.
T h ef o u r t hr e p o r to nt h ed i a g n o s i s ,
evaluation, and treatment of high blood
pressure in children and adolescents.
Pediatrics 2004;114(Suppl. 4th Report):
555–576
10. d’AnnunzioG,VanelliM,PistorioA,etal.;
Diabetes Study Group of the Italian Soci-
ety for Pediatric Endocrinology and Di-
abetes. Insulin resistance and secretion
indexes in healthy Italian children and
adolescents: a multicentre study. Acta
Biomed 2009;80:21–28
11. Tirosh A, Shai I, Tekes-Manova D, et al.;
Israeli Diabetes Research Group. Normal
fasting plasma glucose levels and type 2
diabetes in young men. N Engl J Med
2005;353:1454–1462
12. Sung J, Song YM, Ebrahim S, Lawlor DA.
Fasting blood glucose and the risk of
stroke and myocardial infarction. Circu-
lation 2009;119:812–819
13. Hansen ML, Gunn PW, Kaelber DC. Un-
derdiagnosis of hypertension in children
and adolescents.JAMA2007;298:874–879
14. Lee YJ, Shin YH, Kim JK, Shim JY, Kang
DR, Lee HR. Metabolic syndrome and its
association with white blood cell count in
children and adolescents in Korea: the
2005 Korean National Health and Nutri-
tion Examination Survey. Nutr Metab
Cardiovasc Dis 2010;20:165–172
1414 DIABETES CARE, VOLUME 34, JUNE 2011 care.diabetesjournals.org
Glucose and cardiometabolic risk factors